Literature DB >> 8013948

Fluorescence in situ hybridization: a new tool for the pathologist.

S R Wolman1.   

Abstract

DNA in situ hybridization methods permit investigations of genetic alterations within the context of cell morphology and tissue architecture and are of particular importance in tumor pathology. Detection of specific chromosome aberrations may be a critical adjunct to diagnosis or prognosis when morphology is ambiguous. This approach will lead to better understanding of heterogeneity in tumors and to better definition of premalignant lesions.

Entities:  

Mesh:

Year:  1994        PMID: 8013948     DOI: 10.1016/0046-8177(94)90223-2

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  10 in total

1.  FISHing chromosomes in endocrinology.

Authors:  G Kontogeorgos; K Kovacs
Journal:  Endocrine       Date:  1996-12       Impact factor: 3.633

2.  Subtracted, unique-sequence, in situ hybridization: experimental and diagnostic applications.

Authors:  J M Davison; T W Morgan; B L Hsi; S Xiao; J A Fletcher
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

3.  Numerical chromosome alterations in colorectal carcinomas detected by fluorescence in situ hybridization. Relationship to 17p and 18q allelic losses.

Authors:  A Ooi; C D Huang; M Mai; I Nakanishi
Journal:  Virchows Arch       Date:  1996-07       Impact factor: 4.064

4.  Lack of independent prognostic and predictive value of centromere 17 copy number changes in breast cancer patients with known HER2 and TOP2A status.

Authors:  Kirsten Vang Nielsen; Bent Ejlertsen; Susanne Møller; Maj-Britt Jensen; Eva Balslev; Sven Müller; Ann Knoop; Henning T Mouridsen
Journal:  Mol Oncol       Date:  2011-11-26       Impact factor: 6.603

5.  Origins of heterogeneous ovarian carcinomas. A molecular cytogenetic analysis of histologically benign, low malignant potential, and fully malignant components.

Authors:  N G Wolf; F W Abdul-Karim; N J Schork; S Schwartz
Journal:  Am J Pathol       Date:  1996-08       Impact factor: 4.307

Review 6.  Aneuploidy and malignancy: an unsolved equation.

Authors:  P Dey
Journal:  J Clin Pathol       Date:  2004-12       Impact factor: 3.411

7.  Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers.

Authors:  Ida Marie Heeholm Sønderstrup; Sune Boris Nygård; Tim Svenstrup Poulsen; Dorte Linnemann; Jan Stenvang; Hans Jørgen Nielsen; Jiri Bartek; Nils Brünner; Peter Nørgaard; Lene Riis
Journal:  Mol Oncol       Date:  2015-03-04       Impact factor: 6.603

8.  Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study.

Authors:  A Nasarek; M Werner; M Nolte; J Klempnauer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

Review 9.  Serous effusions: diagnosis of malignancy beyond cytomorphology. An analytic review.

Authors:  S K Mohanty; P Dey
Journal:  Postgrad Med J       Date:  2003-10       Impact factor: 2.401

10.  Interphase cytogenetics reveals a high incidence of aneuploidy and intra-tumour heterogeneity in breast cancer.

Authors:  M Fiegl; C Tueni; T Schenk; R Jakesz; M Gnant; A Reiner; M Rudas; H Pirc-Danoewinata; C Marosi; H Huber
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.